[P4–458]: TARGETING THE APOLIPOPROTEIN E/AMYLOID β INTERACTION BY CPO_A β 17–21P, A NON‐TOXIC AND NON‐FIBRILLOGENIC PEPTOID, AMELIORATED A β ‐RELATED PATHOLOGY AND IMPROVED COGNITIVE DECLINE IN A MOUSE MODEL OF ALZHEIMER's DISEASE